Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
NCT Number: NCT06328699
This clinical trial tests the feasibility, implementation and acceptability of chaplain delivered compassion meditation in order to improve spiritual care for patients receiving stem cell transplantation. Hospital chaplains play a vital role in delivering emotional and spiritual care to a broad range of both religious and non-religious patients for a wide variety of stressors, and extensive research indicates that spiritual consults impact patient outcomes and satisfaction. Compassion meditation is a secularized, research-based mindfulness and compassion meditation program designed to expand and strengthen compassion for self and others. Practices include training in attentional stability and increased emotional awareness, as well as targeted reflections to appreciate one's relationship with self and others. By centering the mind, controlling debilitating ruminative thoughts, and cultivating personal resiliency and an inclusive and more accurate understanding of others. Engaging in chaplain delivered compassion meditation may improve the spiritual care for patients receiving stem cell transplantation.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Atlanta, Georgia, 30322, United States
PRIMARY OBJECTIVE:
I. To examine the feasibility, adoption, extent of implementation, acceptability and fidelity of chaplain-delivered compassion-centered spiritual health (CCSH).
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive chaplain-led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks.
ARM II: Patients receive a traditional chaplain consultation and care upon request, per standard of care.
After completion of study treatment, patients are followed up at 80-100 days and 6 months post treatment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Undergo chaplain led compassionate centered spiritual health sessions
Receive a traditional chaplain consultation and will receive care upon request
Other names: best practice, standard of care, standard of care, standard therapy
Time frame: Up to 8 months
Will measure and characterize the proportion of eligible patient screens who enroll and treatment-specific retention rates.
Time frame: Up to 8 months
We will examine whether scores on the chaplain satisfaction survey vary based on patient sociodemographic variables (biological sex, race)
Time frame: Up to 8 months
Impact of chaplain-delivered compassion-centered spiritual health on quality of life
Time frame: Up to 8 months
Will administer a post- chaplain-based compassion treatment (CBCT) intervention using chaplain satisfaction survey and will ask patients after each session if they would like to continue receiving CBCT sessions.
Emory University
Other
Randomized Pilot Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transplantation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02465060
Adenocarcinoma, Adnexal Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT00352924
Blood Protein Disorders, Cardiovascular Diseases
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT05346809
Blood Protein Disorders, Cardiovascular Diseases
Detroit, Michigan, United States
View Trial DetailsNCT02477878
Anemia, Anemia, Refractory
Atlanta, Georgia, United States
View Trial Details